"ID","Description","GeneRatio","BgRatio","pvalue","p.adjust","qvalue","geneID","Count"
"R-HSA-8939211","ESR-mediated signaling","10/46","189/10179",8.76166011832093e-09,6.20325536377122e-06,3.43088164633198e-06,"ESR2/ESR1/JUN/EGFR/XPO1/MYC/MOV10/HSP90AA1/HSP90AB1/H3C1",10
"R-HSA-3108232","SUMO E3 ligases SUMOylate target proteins","9/46","168/10179",4.78527263813619e-08,1.5299460405137e-05,8.46178898410788e-06,"ESR1/SUMO2/BMI1/SUMO1/TP53/BRCA1/MDM2/NPM1/RNF2",9
"R-HSA-2990846","SUMOylation","9/46","174/10179",6.48282220556652e-08,1.5299460405137e-05,8.46178898410788e-06,"ESR1/SUMO2/BMI1/SUMO1/TP53/BRCA1/MDM2/NPM1/RNF2",9
"R-HSA-2559580","Oxidative Stress Induced Senescence","7/46","92/10179",1.57128476061443e-07,2.54106410690839e-05,1.40540566126958e-05,"JUN/BMI1/TP53/MOV10/MDM2/H3C1/RNF2",7
"R-HSA-9006931","Signaling by Nuclear Receptors","10/46","264/10179",2.07897805355507e-07,2.54106410690839e-05,1.40540566126958e-05,"ESR2/ESR1/JUN/EGFR/XPO1/MYC/MOV10/HSP90AA1/HSP90AB1/H3C1",10
"R-HSA-1257604","PIP3 activates AKT signaling","10/46","265/10179",2.15344415839694e-07,2.54106410690839e-05,1.40540566126958e-05,"ESR2/ESR1/JUN/EGFR/BMI1/TP53/GRB2/MOV10/MDM2/RNF2",10
"R-HSA-5663202","Diseases of signal transduction by growth factor receptors and second messengers","12/46","429/10179",2.84509527147473e-07,2.87761064600587e-05,1.59154201652421e-05,"ESR2/ESR1/EGFR/MYC/GRB2/HSP90AA1/LMNA/MDM2/FN1/CTNNB1/NPM1/SNW1",12
"R-HSA-8864260","Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors","5/46","36/10179",5.11793146594504e-07,4.52936934736136e-05,2.5050927701731e-05,"ESR1/EGFR/SUMO1/MYC/NPM1",5
"R-HSA-2559583","Cellular Senescence","8/46","164/10179",5.93422243352511e-07,4.66825498103975e-05,2.58190730441092e-05,"JUN/BMI1/TP53/MOV10/MDM2/H3C1/CDK2/RNF2",8
"R-HSA-9006925","Intracellular signaling by second messengers","10/46","305/10179",7.88167234575118e-07,5.57564842772783e-05,3.08376630257918e-05,"ESR2/ESR1/JUN/EGFR/BMI1/TP53/GRB2/MOV10/MDM2/RNF2",10
"R-HSA-9018519","Estrogen-dependent gene expression","7/46","118/10179",8.66273060805172e-07,5.57564842772783e-05,3.08376630257918e-05,"ESR1/JUN/MYC/MOV10/HSP90AA1/HSP90AB1/H3C1",7
"R-HSA-3899300","SUMOylation of transcription cofactors","5/46","44/10179",1.43520367833804e-06,8.46770170219443e-05,4.68329621352413e-05,"SUMO2/BMI1/SUMO1/NPM1/RNF2",5
"R-HSA-3232118","SUMOylation of transcription factors","4/46","20/10179",1.67743832392103e-06,9.13558717950836e-05,5.05268871658803e-05,"SUMO2/SUMO1/TP53/MDM2",4
"R-HSA-5688426","Deubiquitination","9/46","268/10179",2.49457101625838e-06,0.000118751422249625,6.56787527161174e-05,"ESR1/TRIM25/CFTR/TP53/BRCA1/MYC/MDM2/TNIP2/NEDD8",9
"R-HSA-9613829","Chaperone Mediated Autophagy","4/46","22/10179",2.51591996291579e-06,0.000118751422249625,6.56787527161174e-05,"CFTR/HSPA8/HSP90AA1/HSP90AB1",4
"R-HSA-157118","Signaling by NOTCH","8/46","203/10179",2.96791417885223e-06,0.000131330202414211,7.26357943771729e-05,"JUN/EGFR/TP53/MYC/MOV10/YWHAZ/H3C1/SNW1",8
"R-HSA-449147","Signaling by Interleukins","11/46","456/10179",4.15548421386054e-06,0.000169445082151861,9.37162809403694e-05,"APP/JUN/TP53/MYC/GRB2/HSPA8/HSP90AA1/YWHAZ/TNIP2/FN1/H3C1",11
"R-HSA-9734009","Defective Intrinsic Pathway for Apoptosis","4/46","25/10179",4.30792581742021e-06,0.000169445082151861,9.37162809403694e-05,"APP/JUN/TP53/LMNA",4
"R-HSA-1912408","Pre-NOTCH Transcription and Translation","5/46","61/10179",7.42533957577541e-06,0.000276691601034157,0.000153031929207116,"JUN/TP53/MOV10/H3C1/SNW1",5
"R-HSA-73894","DNA Repair","9/46","312/10179",8.62884596382335e-06,0.000305461147119346,0.00016894372097591,"TRIM25/SUMO2/RNF4/SUMO1/TP53/BRCA1/COPS5/PCLAF/CDK2",9
"R-HSA-9645723","Diseases of programmed cell death","5/46","71/10179",1.57135242178674e-05,0.00052977024505953,0.000293004060603844,"APP/JUN/TP53/LMNA/H3C1",5
"R-HSA-9009391","Extra-nuclear estrogen signaling","5/46","75/10179",2.05519695701099e-05,0.000661399747983536,0.000365805391391429,"ESR2/ESR1/EGFR/XPO1/HSP90AA1",5
"R-HSA-3108214","SUMOylation of DNA damage response and repair proteins","5/46","76/10179",2.19254920645987e-05,0.00067492384268417,0.000373285265356097,"SUMO2/BMI1/SUMO1/BRCA1/RNF2",5
"R-HSA-1912422","Pre-NOTCH Expression and Processing","5/46","77/10179",2.33694376662978e-05,0.000677825156861735,0.000374889917265188,"JUN/TP53/MOV10/H3C1/SNW1",5
"R-HSA-3371568","Attenuation phase","3/46","13/10179",2.39345041264737e-05,0.000677825156861735,0.000374889917265188,"HSPA8/HSP90AA1/HSP90AB1",3
"R-HSA-69620","Cell Cycle Checkpoints","8/46","273/10179",2.60222377144768e-05,0.000701309160334494,0.000387878393762164,"XPO1/TP53/BRCA1/YWHAZ/MCM2/MDM2/YWHAG/CDK2",8
"R-HSA-5689896","Ovarian tumor domain proteases","4/46","39/10179",2.67448408602138e-05,0.000701309160334494,0.000387878393762164,"ESR1/TRIM25/TP53/TNIP2",4
"R-HSA-3700989","Transcriptional Regulation by TP53","9/46","362/10179",2.82828926836957e-05,0.000715153143573448,0.000395535190914842,"JUN/TP53/BRCA1/MOV10/YWHAZ/MDM2/YWHAG/CDK2/NPM1",9
"R-HSA-5637810","Constitutive Signaling by EGFRvIII","3/46","15/10179",3.78369894868038e-05,0.000892952951888569,0.000493872283827755,"EGFR/GRB2/HSP90AA1",3
"R-HSA-5637812","Signaling by EGFRvIII in Cancer","3/46","15/10179",3.78369894868038e-05,0.000892952951888569,0.000493872283827755,"EGFR/GRB2/HSP90AA1",3
"R-HSA-8856828","Clathrin-mediated endocytosis","6/46","145/10179",4.41295917455022e-05,0.000995946917859467,0.00055083594029694,"EGFR/CFTR/GRB2/HSPA8/COPS5/NEDD8",6
"R-HSA-4655427","SUMOylation of DNA methylation proteins","3/46","16/10179",4.64212546459921e-05,0.000995946917859467,0.00055083594029694,"BMI1/SUMO1/RNF2",3
"R-HSA-9665348","Signaling by ERBB2 ECD mutants","3/46","16/10179",4.64212546459921e-05,0.000995946917859467,0.00055083594029694,"EGFR/GRB2/HSP90AA1",3
"R-HSA-5693532","DNA Double-Strand Break Repair","6/46","149/10179",5.14047018786507e-05,0.0010197103385882,0.000563978956221839,"SUMO2/RNF4/SUMO1/TP53/BRCA1/CDK2",6
"R-HSA-69481","G2/M Checkpoints","6/46","149/10179",5.14047018786507e-05,0.0010197103385882,0.000563978956221839,"TP53/BRCA1/YWHAZ/MCM2/YWHAG/CDK2",6
"R-HSA-4570464","SUMOylation of RNA binding proteins","4/46","46/10179",5.18496782332981e-05,0.0010197103385882,0.000563978956221839,"SUMO2/BMI1/SUMO1/RNF2",4
"R-HSA-8878159","Transcriptional regulation by RUNX3","5/46","96/10179",6.78265941226059e-05,0.00129787104429203,0.000717823414327436,"TP53/MYC/MDM2/CTNNB1/SNW1",5
"R-HSA-1236382","Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants","3/46","19/10179",7.95654935365708e-05,0.00144441972881775,0.000798876210407675,"EGFR/GRB2/HSP90AA1",3
"R-HSA-5637815","Signaling by Ligand-Responsive EGFR Variants in Cancer","3/46","19/10179",7.95654935365708e-05,0.00144441972881775,0.000798876210407675,"EGFR/GRB2/HSP90AA1",3
"R-HSA-5683057","MAPK family signaling cascades","8/46","321/10179",8.21606882660747e-05,0.00145424418230952,0.000804309895657363,"JUN/EGFR/XPO1/CUL3/MYC/GRB2/MOV10/FN1",8
"R-HSA-2219528","PI3K/AKT Signaling in Cancer","5/46","103/10179",9.48833532011304e-05,0.00163847351381464,0.000906203013884993,"ESR2/ESR1/EGFR/GRB2/MDM2",5
"R-HSA-72203","Processing of Capped Intron-Containing Pre-mRNA","7/46","243/10179",9.80004673643175e-05,0.00165200787842707,0.000913688567907923,"ELAVL1/HNRNPL/EFTUD2/NXF1/HSPA8/SNW1/CDC5L",7
"R-HSA-8856825","Cargo recognition for clathrin-mediated endocytosis","5/46","105/10179",0.000103958611285346,0.00171169062302383,0.000946697757604618,"EGFR/CFTR/GRB2/COPS5/NEDD8",5
"R-HSA-6785807","Interleukin-4 and Interleukin-13 signaling","5/46","107/10179",0.000113687232784828,0.00182933092753768,0.00101176197597981,"TP53/MYC/HSPA8/HSP90AA1/FN1",5
"R-HSA-4551638","SUMOylation of chromatin organization proteins","4/46","57/10179",0.000121036583647517,0.00184751324683229,0.00102181820966638,"SUMO2/BMI1/SUMO1/RNF2",4
"R-HSA-8862803","Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models","3/46","22/10179",0.00012525513537846,0.00184751324683229,0.00102181820966638,"APP/JUN/LMNA",3
"R-HSA-8863678","Neurodegenerative Diseases","3/46","22/10179",0.00012525513537846,0.00184751324683229,0.00102181820966638,"APP/JUN/LMNA",3
"R-HSA-9665686","Signaling by ERBB2 TMD/JMD mutants","3/46","22/10179",0.00012525513537846,0.00184751324683229,0.00102181820966638,"EGFR/GRB2/HSP90AA1",3
"R-HSA-3371571","HSF1-dependent transactivation","3/46","23/10179",0.000143588074603322,0.00203320713638303,0.00112452134215654,"HSPA8/HSP90AA1/HSP90AB1",3
"R-HSA-9013418","RHOBTB2 GTPase cycle","3/46","23/10179",0.000143588074603322,0.00203320713638303,0.00112452134215654,"CUL3/HSP90AA1/HSP90AB1",3
"R-HSA-8943724","Regulation of PTEN gene transcription","4/46","60/10179",0.000147947597184411,0.002053860760913,0.00113594439943449,"JUN/BMI1/TP53/RNF2",4
"R-HSA-72163","mRNA Splicing - Major Pathway","6/46","183/10179",0.000160313177188178,0.00218272556633134,0.00120721663793526,"ELAVL1/HNRNPL/EFTUD2/HSPA8/SNW1/CDC5L",6
"R-HSA-1643713","Signaling by EGFR in Cancer","3/46","25/10179",0.000185301186061645,0.0024295044394749,0.00134370450711368,"EGFR/GRB2/HSP90AA1",3
"R-HSA-9664565","Signaling by ERBB2 KD Mutants","3/46","25/10179",0.000185301186061645,0.0024295044394749,0.00134370450711368,"EGFR/GRB2/HSP90AA1",3
"R-HSA-3065676","SUMO is conjugated to E1 (UBA2:SAE1)","2/46","5/10179",0.000198081138696837,0.00254984447631564,0.00141026188698992,"SUMO2/SUMO1",2
"R-HSA-72172","mRNA Splicing","6/46","191/10179",0.000202411031804512,0.00255905375924276,0.00141535533517441,"ELAVL1/HNRNPL/EFTUD2/HSPA8/SNW1/CDC5L",6
"R-HSA-1227990","Signaling by ERBB2 in Cancer","3/46","26/10179",0.000208809028603835,0.00259362793423711,0.00143447753722302,"EGFR/GRB2/HSP90AA1",3
"R-HSA-69275","G2/M Transition","6/46","193/10179",0.000214190751626426,0.00261460434743982,0.00144607912168839,"XPO1/TP53/HSP90AA1/YWHAG/HSP90AB1/CDK2",6
"R-HSA-9679506","SARS-CoV Infections","8/46","370/10179",0.000219556059788616,0.00263467271746339,0.00145717848780313,"TRIM25/CUL3/SUMO1/GRB2/HSP90AA1/YWHAZ/YWHAG/HSP90AB1",8
"R-HSA-453274","Mitotic G2-G2/M phases","6/46","195/10179",0.000226506117359195,0.0026727721848385,0.00147825045013369,"XPO1/TP53/HSP90AA1/YWHAG/HSP90AB1/CDK2",6
"R-HSA-201681","TCF dependent signaling in response to WNT","6/46","200/10179",0.000259752375203114,0.00301483084661975,0.00166743543702431,"XPO1/CUL3/MYC/YWHAZ/H3C1/CTNNB1",6
"R-HSA-195258","RHO GTPase Effectors","7/46","288/10179",0.00028024895163889,0.00320026222194087,0.00176999337877193,"CFTR/XPO1/GRB2/YWHAZ/YWHAG/H3C1/CTNNB1",7
"R-HSA-3065679","SUMO is proteolytically processed","2/46","6/10179",0.000296266049373606,0.00322702096856174,0.00178479304238027,"SUMO2/SUMO1",2
"R-HSA-5336415","Uptake and function of diphtheria toxin","2/46","6/10179",0.000296266049373606,0.00322702096856174,0.00178479304238027,"HSP90AA1/HSP90AB1",2
"R-HSA-8857538","PTK6 promotes HIF1A stabilization","2/46","6/10179",0.000296266049373606,0.00322702096856174,0.00178479304238027,"LRRK2/EGFR",2
"R-HSA-5357801","Programmed Cell Death","6/46","208/10179",0.000320837548136545,0.00335220418352975,0.00185402907563644,"TP53/HSP90AA1/YWHAZ/LMNA/YWHAG/CTNNB1",6
"R-HSA-114452","Activation of BH3-only proteins","3/46","30/10179",0.000321963113672349,0.00335220418352975,0.00185402907563644,"TP53/YWHAZ/YWHAG",3
"R-HSA-4090294","SUMOylation of intracellular receptors","3/46","30/10179",0.000321963113672349,0.00335220418352975,0.00185402907563644,"ESR1/SUMO2/SUMO1",3
"R-HSA-195721","Signaling by WNT","7/46","297/10179",0.000337931223572365,0.00346746820709036,0.00191777902622303,"XPO1/CUL3/MYC/MOV10/YWHAZ/H3C1/CTNNB1",7
"R-HSA-69473","G2/M DNA damage checkpoint","4/46","76/10179",0.000369263168587606,0.0037348331908575,0.00206565261224946,"TP53/BRCA1/YWHAZ/YWHAG",4
"R-HSA-6807070","PTEN Regulation","5/46","139/10179",0.000386187063203644,0.00381745978905078,0.00211135153364093,"JUN/BMI1/TP53/MOV10/RNF2",5
"R-HSA-2219530","Constitutive Signaling by Aberrant PI3K in Cancer","4/46","77/10179",0.000388216249733978,0.00381745978905078,0.00211135153364093,"ESR2/ESR1/EGFR/GRB2",4
"R-HSA-3065678","SUMO is transferred from E1 to E2 (UBE2I, UBC9)","2/46","7/10179",0.000413578341941581,0.00401114337115944,0.00221847358618988,"SUMO2/SUMO1",2
"R-HSA-5693607","Processing of DNA double-strand break ends","4/46","79/10179",0.000428195811680933,0.0040458201953006,0.0022376525611832,"SUMO2/RNF4/BRCA1/CDK2",4
"R-HSA-2559585","Oncogene Induced Senescence","3/46","33/10179",0.000428582647807267,0.0040458201953006,0.0022376525611832,"TP53/MOV10/MDM2",3
"R-HSA-168928","DDX58/IFIH1-mediated induction of interferon-alpha/beta","4/46","80/10179",0.000449250895606134,0.00418512676433083,0.00231469990533909,"APP/TRIM25/HSP90AA1/HSP90AB1",4
"R-HSA-8953750","Transcriptional Regulation by E2F6","3/46","34/10179",0.000468574774501726,0.00430845377074314,0.00238290931120495,"BMI1/BRCA1/RNF2",3
"R-HSA-9706574","RHOBTB GTPase Cycle","3/46","35/10179",0.000510886306572611,0.00463727570581293,0.00256477336093133,"CUL3/HSP90AA1/HSP90AB1",3
"R-HSA-4411364","Binding of TCF/LEF:CTNNB1 to target gene promoters","2/46","8/10179",0.000549850662919085,0.00479688949325719,0.00265305217289872,"MYC/CTNNB1",2
"R-HSA-450520","HuR (ELAVL1) binds and stabilizes mRNA","2/46","8/10179",0.000549850662919085,0.00479688949325719,0.00265305217289872,"ELAVL1/XPO1",2
"R-HSA-8951430","RUNX3 regulates WNT signaling","2/46","8/10179",0.000549850662919085,0.00479688949325719,0.00265305217289872,"MYC/CTNNB1",2
"R-HSA-6804757","Regulation of TP53 Degradation","3/46","36/10179",0.000555571946959167,0.00479688949325719,0.00265305217289872,"TP53/MDM2/CDK2",3
"R-HSA-1500620","Meiosis","4/46","86/10179",0.000591403910478337,0.0050447466098634,0.00279013639439367,"BRCA1/LMNA/H3C1/CDK2",4
"R-HSA-6806003","Regulation of TP53 Expression and Degradation","3/46","37/10179",0.000602685571668621,0.00507977838977838,0.00280951168747778,"TP53/MDM2/CDK2",3
"R-HSA-450531","Regulation of mRNA stability by proteins that bind AU-rich elements","4/46","87/10179",0.000617868672506715,0.00508663976900877,0.00281330656269888,"ELAVL1/XPO1/HSPA8/YWHAZ",4
"R-HSA-5628897","TP53 Regulates Metabolic Genes","4/46","87/10179",0.000617868672506715,0.00508663976900877,0.00281330656269888,"TP53/MOV10/YWHAZ/YWHAG",4
"R-HSA-5687128","MAPK6/MAPK4 signaling","4/46","89/10179",0.000673306157004061,0.00547931907079167,0.00303048869214169,"JUN/XPO1/MYC/MOV10",4
"R-HSA-8853884","Transcriptional Regulation by VENTX","3/46","39/10179",0.000704408186669553,0.00560765214210167,0.00310146684041306,"TP53/MOV10/CTNNB1",3
"R-HSA-2179392","EGFR Transactivation by Gastrin","2/46","9/10179",0.000704916724077752,0.00560765214210167,0.00310146684041306,"EGFR/GRB2",2
"R-HSA-6804756","Regulation of TP53 Activity through Phosphorylation","4/46","92/10179",0.000762952665238479,0.00600189429987604,0.00331951335051128,"TP53/BRCA1/MDM2/CDK2",4
"R-HSA-170834","Signaling by TGF-beta Receptor Complex","4/46","93/10179",0.000794624504168457,0.00618235328517877,0.00341932117467514,"XPO1/MYC/NEDD8/SNW1",4
"R-HSA-168142","Toll Like Receptor 10 (TLR10) Cascade","4/46","95/10179",0.000860741304089695,0.00647975831217334,0.00358380923599239,"APP/JUN/TP53/TNIP2",4
"R-HSA-168176","Toll Like Receptor 5 (TLR5) Cascade","4/46","95/10179",0.000860741304089695,0.00647975831217334,0.00358380923599239,"APP/JUN/TP53/TNIP2",4
"R-HSA-975871","MyD88 cascade initiated on plasma membrane","4/46","95/10179",0.000860741304089695,0.00647975831217334,0.00358380923599239,"APP/JUN/TP53/TNIP2",4
"R-HSA-3769402","Deactivation of the beta-catenin transactivating complex","3/46","42/10179",0.000876502140074912,0.00647975831217334,0.00358380923599239,"XPO1/YWHAZ/CTNNB1",3
"R-HSA-3215018","Processing and activation of SUMO","2/46","10/10179",0.000878611296565877,0.00647975831217334,0.00358380923599239,"SUMO2/SUMO1",2
"R-HSA-9679191","Potential therapeutics for SARS","4/46","97/10179",0.000930654258117895,0.00679281664688113,0.00375695479131695,"CUL3/GRB2/HSP90AA1/HSP90AB1",4
"R-HSA-975138","TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation","4/46","100/10179",0.00104290080321406,0.00753442621097507,0.00416712243604331,"APP/JUN/TP53/TNIP2",4
"R-HSA-9614399","Regulation of localization of FOXO transcription factors","2/46","11/10179",0.00107077020506144,0.00758105305183502,0.00419291069771428,"YWHAZ/YWHAG",2
"R-HSA-9634285","Constitutive Signaling by Overexpressed ERBB2","2/46","11/10179",0.00107077020506144,0.00758105305183502,0.00419291069771428,"GRB2/HSP90AA1",2
"R-HSA-975155","MyD88 dependent cascade initiated on endosome","4/46","101/10179",0.00108234287316226,0.00758711637820675,0.00419626418776823,"APP/JUN/TP53/TNIP2",4
"R-HSA-168181","Toll Like Receptor 7/8 (TLR7/8) Cascade","4/46","102/10179",0.00112282294696822,0.00779371222013233,0.00431052772210709,"APP/JUN/TP53/TNIP2",4
"R-HSA-168164","Toll Like Receptor 3 (TLR3) Cascade","4/46","103/10179",0.0011643558598477,0.00800353348322493,0.00442657516467392,"APP/JUN/TP53/TNIP2",4
"R-HSA-109581","Apoptosis","5/46","179/10179",0.00121575813328411,0.00826500453352161,0.00457118894806726,"TP53/YWHAZ/LMNA/YWHAG/CTNNB1",5
"R-HSA-168138","Toll Like Receptor 9 (TLR9) Cascade","4/46","105/10179",0.00125063952641659,0.00826500453352161,0.00457118894806726,"APP/JUN/TP53/TNIP2",4
"R-HSA-6811558","PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling","4/46","105/10179",0.00125063952641659,0.00826500453352161,0.00457118894806726,"ESR2/ESR1/EGFR/GRB2",4
"R-HSA-3371511","HSF1 activation","2/46","12/10179",0.00128123032195464,0.00826500453352161,0.00457118894806726,"HSP90AA1/HSP90AB1",2
"R-HSA-9700645","ALK mutants bind TKIs","2/46","12/10179",0.00128123032195464,0.00826500453352161,0.00457118894806726,"FN1/NPM1",2
"R-HSA-9755779","SARS-CoV-2 targets host intracellular signalling and regulatory pathways","2/46","12/10179",0.00128123032195464,0.00826500453352161,0.00457118894806726,"YWHAZ/YWHAG",2
"R-HSA-1474165","Reproduction","4/46","106/10179",0.00129541992768484,0.00826500453352161,0.00457118894806726,"BRCA1/LMNA/H3C1/CDK2",4
"R-HSA-6791312","TP53 Regulates Transcription of Cell Cycle Genes","3/46","48/10179",0.00129578460906907,0.00826500453352161,0.00457118894806726,"TP53/CDK2/NPM1",3
"R-HSA-166166","MyD88-independent TLR4 cascade ","4/46","107/10179",0.00134131245952561,0.00840397541012508,0.0046480506282583,"APP/JUN/TP53/TNIP2",4
"R-HSA-937061","TRIF(TICAM1)-mediated TLR4 signaling ","4/46","107/10179",0.00134131245952561,0.00840397541012508,0.0046480506282583,"APP/JUN/TP53/TNIP2",4
"R-HSA-1227986","Signaling by ERBB2","3/46","50/10179",0.00145916187285671,0.00906216321037326,0.00501207956327513,"EGFR/GRB2/HSP90AA1",3
"R-HSA-179812","GRB2 events in EGFR signaling","2/46","13/10179",0.00150982956155976,0.00913640452636163,0.00505314077283159,"EGFR/GRB2",2
"R-HSA-75035","Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex","2/46","13/10179",0.00150982956155976,0.00913640452636163,0.00505314077283159,"YWHAZ/YWHAG",2
"R-HSA-8866910","TFAP2 (AP-2) family regulates transcription of growth factors and their receptors","2/46","13/10179",0.00150982956155976,0.00913640452636163,0.00505314077283159,"ESR1/EGFR",2
"R-HSA-166058","MyD88:MAL(TIRAP) cascade initiated on plasma membrane","4/46","111/10179",0.00153629972746638,0.00914033787433777,0.00505531621952669,"APP/JUN/TP53/TNIP2",4
"R-HSA-168188","Toll Like Receptor TLR6:TLR2 Cascade","4/46","111/10179",0.00153629972746638,0.00914033787433777,0.00505531621952669,"APP/JUN/TP53/TNIP2",4
"R-HSA-199418","Negative regulation of the PI3K/AKT network","4/46","112/10179",0.00158797466373067,0.00936905051601093,0.0051818120605948,"ESR2/ESR1/EGFR/GRB2",4
"R-HSA-3371497","HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand","3/46","52/10179",0.00163493590047931,0.00944489453634631,0.00522375969003989,"HSPA8/HSP90AA1/HSP90AB1",3
"R-HSA-9694516","SARS-CoV-2 Infection","6/46","284/10179",0.00163946188000814,0.00944489453634631,0.00522375969003989,"TRIM25/SUMO1/HSP90AA1/YWHAZ/YWHAG/HSP90AB1",6
"R-HSA-5693567","HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA)","4/46","113/10179",0.00164085032199237,0.00944489453634631,0.00522375969003989,"SUMO2/RNF4/BRCA1/CDK2",4
"R-HSA-168179","Toll Like Receptor TLR1:TLR2 Cascade","4/46","114/10179",0.00169494140504507,0.00960014811817525,0.00530962696990959,"APP/JUN/TP53/TNIP2",4
"R-HSA-181438","Toll Like Receptor 2 (TLR2) Cascade","4/46","114/10179",0.00169494140504507,0.00960014811817525,0.00530962696990959,"APP/JUN/TP53/TNIP2",4
"R-HSA-180336","SHC1 events in EGFR signaling","2/46","14/10179",0.00175640687435633,0.00979162257515184,0.0054155272048119,"EGFR/GRB2",2
"R-HSA-6804116","TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest","2/46","14/10179",0.00175640687435633,0.00979162257515184,0.0054155272048119,"TP53/CDK2",2
"R-HSA-8848021","Signaling by PTK6","3/46","54/10179",0.00182344231990686,0.00993074740380043,0.005492474032432,"LRRK2/EGFR/CDK2",3
"R-HSA-9006927","Signaling by Non-Receptor Tyrosine Kinases","3/46","54/10179",0.00182344231990686,0.00993074740380043,0.005492474032432,"LRRK2/EGFR/CDK2",3
"R-HSA-912446","Meiotic recombination","3/46","54/10179",0.00182344231990686,0.00993074740380043,0.005492474032432,"BRCA1/H3C1/CDK2",3
"R-HSA-109606","Intrinsic Pathway for Apoptosis","3/46","55/10179",0.0019225719446282,0.0102344431338103,0.00566044134073361,"TP53/YWHAZ/YWHAG",3
"R-HSA-9700206","Signaling by ALK in cancer","3/46","55/10179",0.0019225719446282,0.0102344431338103,0.00566044134073361,"GRB2/FN1/NPM1",3
"R-HSA-9725370","Signaling by ALK fusions and activated point mutants","3/46","55/10179",0.0019225719446282,0.0102344431338103,0.00566044134073361,"GRB2/FN1/NPM1",3
"R-HSA-9705683","SARS-CoV-2-host interactions","5/46","199/10179",0.001941871982637,0.0102600400276641,0.00567459840959123,"TRIM25/HSP90AA1/YWHAZ/YWHAG/HSP90AB1",5
"R-HSA-5693538","Homology Directed Repair","4/46","119/10179",0.00198414114483268,0.0104057180040114,0.00575516963647373,"SUMO2/RNF4/BRCA1/CDK2",4
"R-HSA-111447","Activation of BAD and translocation to mitochondria ","2/46","15/10179",0.00202080224125934,0.0104432699767271,0.00577593879176699,"YWHAZ/YWHAG",2
"R-HSA-354194","GRB2:SOS provides linkage to MAPK signaling for Integrins ","2/46","15/10179",0.00202080224125934,0.0104432699767271,0.00577593879176699,"GRB2/FN1",2
"R-HSA-9006936","Signaling by TGFB family members","4/46","122/10179",0.00217318163374174,0.011149366642675,0.00616646504768823,"XPO1/MYC/NEDD8/SNW1",4
"R-HSA-1236394","Signaling by ERBB4","3/46","58/10179",0.00223993818084251,0.0112442932474912,0.00621896682733677,"ESR1/EGFR/GRB2",3
"R-HSA-9616222","Transcriptional regulation of granulopoiesis","3/46","58/10179",0.00223993818084251,0.0112442932474912,0.00621896682733677,"MYC/H3C1/CDK2",3
"R-HSA-8878171","Transcriptional regulation by RUNX1","5/46","206/10179",0.00225871673903566,0.0112442932474912,0.00621896682733677,"ESR1/BMI1/MOV10/H3C1/RNF2",5
"R-HSA-1963640","GRB2 events in ERBB2 signaling","2/46","16/10179",0.00230285666791839,0.0112442932474912,0.00621896682733677,"EGFR/GRB2",2
"R-HSA-1963642","PI3K events in ERBB2 signaling","2/46","16/10179",0.00230285666791839,0.0112442932474912,0.00621896682733677,"EGFR/GRB2",2
"R-HSA-399954","Sema3A PAK dependent Axon repulsion","2/46","16/10179",0.00230285666791839,0.0112442932474912,0.00621896682733677,"HSP90AA1/HSP90AB1",2
"R-HSA-844456","The NLRP3 inflammasome","2/46","16/10179",0.00230285666791839,0.0112442932474912,0.00621896682733677,"APP/HSP90AB1",2
"R-HSA-201722","Formation of the beta-catenin:TCF transactivating complex","3/46","59/10179",0.00235251306190035,0.0113304710736425,0.00626662985339729,"MYC/H3C1/CTNNB1",3
"R-HSA-5693565","Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks","3/46","59/10179",0.00235251306190035,0.0113304710736425,0.00626662985339729,"SUMO1/TP53/BRCA1",3
"R-HSA-5693606","DNA Double Strand Break Response","3/46","60/10179",0.00246854282320119,0.0118089751272057,0.00653127973137158,"SUMO1/TP53/BRCA1",3
"R-HSA-2029482","Regulation of actin dynamics for phagocytic cup formation","3/46","61/10179",0.00258806354811274,0.0122833854850958,0.00679366547792989,"GRB2/HSP90AA1/HSP90AB1",3
"R-HSA-180292","GAB1 signalosome","2/46","17/10179",0.00260241217904572,0.0122833854850958,0.00679366547792989,"EGFR/GRB2",2
"R-HSA-5625740","RHO GTPases activate PKNs","3/46","62/10179",0.00271111065917259,0.0126280680703566,0.00698430169814547,"YWHAZ/YWHAG/H3C1",3
"R-HSA-6796648","TP53 Regulates Transcription of DNA Repair Genes","3/46","62/10179",0.00271111065917259,0.0126280680703566,0.00698430169814547,"JUN/TP53/BRCA1",3
"R-HSA-881907","Gastrin-CREB signalling pathway via PKC and MAPK","2/46","18/10179",0.0029193118127729,0.0135089723100863,0.00747151010905757,"EGFR/GRB2",2
"R-HSA-69563","p53-Dependent G1 DNA Damage Response","3/46","66/10179",0.00323924862449075,0.0146713817034744,0.00811441271735427,"TP53/MDM2/CDK2",3
"R-HSA-69580","p53-Dependent G1/S DNA damage checkpoint","3/46","66/10179",0.00323924862449075,0.0146713817034744,0.00811441271735427,"TP53/MDM2/CDK2",3
"R-HSA-6804760","Regulation of TP53 Activity through Methylation","2/46","19/10179",0.00325339961503599,0.0146713817034744,0.00811441271735427,"TP53/MDM2",2
"R-HSA-9725371","Nuclear events stimulated by ALK signaling in cancer","2/46","19/10179",0.00325339961503599,0.0146713817034744,0.00811441271735427,"FN1/NPM1",2
"R-HSA-69615","G1/S DNA Damage Checkpoints","3/46","68/10179",0.0035253493491191,0.015797135058078,0.00873704169135446,"TP53/MDM2/CDK2",3
"R-HSA-167044","Signalling to RAS","2/46","20/10179",0.00360452063398928,0.0158509354587851,0.00876679748835575,"NTRK1/GRB2",2
"R-HSA-6804115","TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain","2/46","20/10179",0.00360452063398928,0.0158509354587851,0.00876679748835575,"TP53/NPM1",2
"R-HSA-8876384","Listeria monocytogenes entry into host cells","2/46","20/10179",0.00360452063398928,0.0158509354587851,0.00876679748835575,"GRB2/CTNNB1",2
"R-HSA-166016","Toll Like Receptor 4 (TLR4) Cascade","4/46","143/10179",0.00385728172628487,0.0168577497667265,0.00932364393877825,"APP/JUN/TP53/TNIP2",4
"R-HSA-622312","Inflammasomes","2/46","21/10179",0.0039725209144471,0.0172548761191935,0.0095432856323818,"APP/HSP90AB1",2
"R-HSA-9612973","Autophagy","4/46","147/10179",0.00425616369726052,0.0183741701076857,0.0101623420756156,"CFTR/HSPA8/HSP90AA1/HSP90AB1",4
"R-HSA-1250196","SHC1 events in ERBB2 signaling","2/46","22/10179",0.00435724749235396,0.0186965528762824,0.0103406447665434,"EGFR/GRB2",2
"R-HSA-8852276","The role of GTSE1 in G2/M progression after G2 checkpoint","3/46","75/10179",0.00464657573100863,0.0198179254069525,0.0109608508049157,"TP53/HSP90AA1/HSP90AB1",3
"R-HSA-933542","TRAF6 mediated NF-kB activation","2/46","24/10179",0.00517627260695989,0.0217254978270627,0.0120158863985538,"APP/TRIM25",2
"R-HSA-9634638","Estrogen-dependent nuclear events downstream of ESR-membrane signaling","2/46","24/10179",0.00517627260695989,0.0217254978270627,0.0120158863985538,"EGFR/XPO1",2
"R-HSA-9663891","Selective autophagy","3/46","78/10179",0.00518588860561242,0.0217254978270627,0.0120158863985538,"CFTR/HSPA8/HSP90AA1",3
"R-HSA-2559582","Senescence-Associated Secretory Phenotype (SASP)","3/46","80/10179",0.00556555362072263,0.0231788939027743,0.0128197272254416,"JUN/H3C1/CDK2",3
"R-HSA-69273","Cyclin A/B1/B2 associated events during G2/M transition","2/46","25/10179",0.0056102701218206,0.0232284868201695,0.0128471559576317,"XPO1/CDK2",2
"R-HSA-5633007","Regulation of TP53 Activity","4/46","160/10179",0.00574386603484795,0.0236433555387927,0.0130766105566918,"TP53/BRCA1/MDM2/CDK2",4
"R-HSA-9660826","Purinergic signaling in leishmaniasis infection","2/46","26/10179",0.00606039187958866,0.0246595255790159,0.0136386314531578,"APP/HSP90AB1",2
"R-HSA-9664424","Cell recruitment (pro-inflammatory response)","2/46","26/10179",0.00606039187958866,0.0246595255790159,0.0136386314531578,"APP/HSP90AB1",2
"R-HSA-5696399","Global Genome Nucleotide Excision Repair (GG-NER)","3/46","84/10179",0.00637404713327815,0.0257380799175229,0.014235155708175,"SUMO2/SUMO1/COPS5",3
"R-HSA-168898","Toll-like Receptor Cascades","4/46","165/10179",0.00639816675915824,0.0257380799175229,0.014235155708175,"APP/JUN/TP53/TNIP2",4
"R-HSA-1538133","G0 and Early G1","2/46","27/10179",0.00652648978988596,0.0258142724650238,0.0142772961001916,"MYC/CDK2",2
"R-HSA-354192","Integrin signaling","2/46","27/10179",0.00652648978988596,0.0258142724650238,0.0142772961001916,"GRB2/FN1",2
"R-HSA-5218920","VEGFR2 mediated vascular permeability","2/46","27/10179",0.00652648978988596,0.0258142724650238,0.0142772961001916,"HSP90AA1/CTNNB1",2
"R-HSA-2029480","Fcgamma receptor (FCGR) dependent phagocytosis","3/46","85/10179",0.0065865456037319,0.0259070793746788,0.014328625523908,"GRB2/HSP90AA1/HSP90AB1",3
"R-HSA-68886","M Phase","6/46","380/10179",0.00689312682695211,0.0269631701297353,0.0149127256738946,"XPO1/SUMO1/HSP90AA1/LMNA/YWHAG/H3C1",6
"R-HSA-3371556","Cellular response to heat stress","3/46","88/10179",0.00724928393489947,0.0282005111313672,0.0155970712769381,"HSPA8/HSP90AA1/HSP90AB1",3
"R-HSA-5339562","Uptake and actions of bacterial toxins","2/46","29/10179",0.00750602649388967,0.0288818845525755,0.0159739236597652,"HSP90AA1/HSP90AB1",2
"R-HSA-8863795","Downregulation of ERBB2 signaling","2/46","29/10179",0.00750602649388967,0.0288818845525755,0.0159739236597652,"EGFR/HSP90AA1",2
"R-HSA-182971","EGFR downregulation","2/46","31/10179",0.00854771458561892,0.0325364619710656,0.017995188601303,"EGFR/GRB2",2
"R-HSA-9022692","Regulation of MECP2 expression and activity","2/46","31/10179",0.00854771458561892,0.0325364619710656,0.017995188601303,"HTT/MOV10",2
"R-HSA-187042","TRKA activation by NGF","1/46","2/10179",0.00901823559889248,0.0333512213879896,0.0184458137917516,"NTRK1",1
"R-HSA-192905","vRNP Assembly","1/46","2/10179",0.00901823559889248,0.0333512213879896,0.0184458137917516,"HSP90AA1",1
"R-HSA-6804754","Regulation of TP53 Expression","1/46","2/10179",0.00901823559889248,0.0333512213879896,0.0184458137917516,"TP53",1
"R-HSA-9663199","Defective DNA double strand break response due to BRCA1 loss of function","1/46","2/10179",0.00901823559889248,0.0333512213879896,0.0184458137917516,"BRCA1",1
"R-HSA-9699150","Defective DNA double strand break response due to BARD1 loss of function","1/46","2/10179",0.00901823559889248,0.0333512213879896,0.0184458137917516,"BRCA1",1
"R-HSA-2871796","FCERI mediated MAPK activation","2/46","32/10179",0.00909150526537005,0.0333512213879896,0.0184458137917516,"JUN/GRB2",2
"R-HSA-5656169","Termination of translesion DNA synthesis","2/46","32/10179",0.00909150526537005,0.0333512213879896,0.0184458137917516,"TRIM25/PCLAF",2
"R-HSA-68962","Activation of the pre-replicative complex","2/46","33/10179",0.0096504034987612,0.0352189983356852,0.0194788394006466,"MCM2/CDK2",2
"R-HSA-187687","Signalling to ERKs","2/46","34/10179",0.0102242677940274,0.0367450842546772,0.0203228833522746,"NTRK1/GRB2",2
"R-HSA-4085377","SUMOylation of SUMOylation proteins","2/46","34/10179",0.0102242677940274,0.0367450842546772,0.0203228833522746,"SUMO2/SUMO1",2
"R-HSA-9615710","Late endosomal microautophagy","2/46","34/10179",0.0102242677940274,0.0367450842546772,0.0203228833522746,"CFTR/HSPA8",2
"R-HSA-5689880","Ub-specific processing proteases","4/46","190/10179",0.0104173574438311,0.0372499447991535,0.0206021104152321,"CFTR/TP53/MYC/MDM2",4
"R-HSA-432720","Lysosome Vesicle Biogenesis","2/46","35/10179",0.0108129575811459,0.0384702209419663,0.0212770178269573,"APP/HSPA8",2
"R-HSA-177243","Interactions of Rev with host cellular proteins","2/46","36/10179",0.0114163332066863,0.0404138195516694,0.0223519786994068,"XPO1/NPM1",2
"R-HSA-176187","Activation of ATR in response to replication stress","2/46","37/10179",0.0120342559286873,0.0421794712748049,0.0233285211332552,"MCM2/CDK2",2
"R-HSA-8939243","RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known","2/46","37/10179",0.0120342559286873,0.0421794712748049,0.0233285211332552,"BMI1/RNF2",2
"R-HSA-111465","Apoptotic cleavage of cellular proteins","2/46","38/10179",0.0126665879115593,0.0439605109871763,0.0243135743194017,"LMNA/CTNNB1",2
"R-HSA-3232142","SUMOylation of ubiquitinylation proteins","2/46","38/10179",0.0126665879115593,0.0439605109871763,0.0243135743194017,"SUMO1/MDM2",2
"R-HSA-5696398","Nucleotide Excision Repair","3/46","110/10179",0.0133084413359631,0.0452900864906722,0.025048932760229,"SUMO2/SUMO1/COPS5",3
"R-HSA-110313","Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template","2/46","39/10179",0.0133131922210127,0.0452900864906722,0.025048932760229,"TRIM25/PCLAF",2
"R-HSA-76009","Platelet Aggregation (Plug Formation)","2/46","39/10179",0.0133131922210127,0.0452900864906722,0.025048932760229,"GRB2/FN1",2
"R-HSA-167021","PLC-gamma1 signalling","1/46","3/10179",0.0134974692789998,0.0452900864906722,0.025048932760229,"NTRK1",1
"R-HSA-198745","Signalling to STAT3","1/46","3/10179",0.0134974692789998,0.0452900864906722,0.025048932760229,"NTRK1",1
"R-HSA-352238","Breakdown of the nuclear lamina","1/46","3/10179",0.0134974692789998,0.0452900864906722,0.025048932760229,"LMNA",1
"R-HSA-5627083","RHO GTPases regulate CFTR trafficking","1/46","3/10179",0.0134974692789998,0.0452900864906722,0.025048932760229,"CFTR",1
"R-HSA-9646399","Aggrephagy","2/46","40/10179",0.013973932819013,0.0466676624333076,0.0258108391691799,"CFTR/HSP90AA1",2
"R-HSA-9020702","Interleukin-1 signaling","3/46","113/10179",0.0143031954849797,0.0475430159782424,0.026294977615085,"APP/TP53/TNIP2",3
"R-HSA-8875878","MET promotes cell motility","2/46","41/10179",0.01464867455876,0.0484638391944022,0.0268042643180458,"GRB2/FN1",2
